This compound is primarily utilized in organic synthesis and pharmaceutical research, particularly in the development of novel drug candidates. Its structure, featuring a dioxaborolane group, makes it a valuable intermediate in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct complex organic molecules, including bioactive compounds. The presence of the trifluoromethylpyridine moiety enhances its potential in medicinal chemistry, as this group often improves metabolic stability and binding affinity in drug molecules. Researchers leverage this chemical to explore treatments for various diseases, including cancer and neurological disorders, by incorporating it into targeted small-molecule inhibitors or receptor modulators. Its unique properties also make it suitable for use in materials science, particularly in the design of advanced polymers or functionalized materials with specific electronic or optical characteristics.